BGR vs GCBC

The Advanced Deterministic Scorecard reveals significant financial health concerns, with a weak Piotroski F-Score of 4/9 indicating borderline stability and no available Altman Z-Score to mitigate bankruptcy risk. Despite a high dividend yield of 7.84%, the unsustainable payout ratio of over 10,600% and negative profit margin highlight severe earnings and cash flow deficiencies. Valuation metrics are distorted, with an extremely high P/E of 1500 and Price/Sales of 28.82, far above sector averages, while technical trend signals strong bearishness at 10/100. Although historical price performance shows strong momentum (+22.1% over 1Y), fundamentals do not support this premium, raising concerns of overvaluation.

GCBC presents a conflicting profile: it is fundamentally undervalued with a Piotroski F-Score of 3/9 indicating weak operational health, yet it exhibits strong growth and value metrics. The stock trades significantly below its Graham Number ($27.09) and Intrinsic Value ($63.42), suggesting a deep discount. However, the bearish technical trend (0/100) and poor health score offset the aggressive YoY earnings growth of 36.40%. The overall outlook remains neutral until fundamental health improves to match the growth trajectory.